• Gastroesophageal reflux disease and proton pump inhibitors. PPIs have played a significant role in reducing refractory esophageal strictures resulting from GERD, as well as mitigating upper GI disease complications in general.
• Colorectal cancer screening. Over the past 20 years, colonoscopy has become the gold standard for colorectal cancer screening. Additionally, new technologies have joined the ranks of CRC screening options.
• Hepatitis C treatment. New treatments for HCV are effective, with significantly reduced side effects.
• Fecal microbiota transplantation. FMT has demonstrated efficacy in treating refractory Clostridium difficile infection.
More articles on gastroenterology:
3 GI physicians making headlines – June 19, 2015
Keeping up with quality reporting in GI: 2 gastroenterologists weigh in
ASGE names Dr. Douglas Faigel president: 5 key points
